NeuroSense Therapeutics L... (NRSN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.03
0.00 (0.00%)
At close: Jan 15, 2025, 11:18 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 97.00K | 89.00K | 3.00K | 3.00K | n/a |
Gross Profit | -97.00K | -89.00K | -3.00K | -3.00K | n/a |
Operating Income | -12.05M | -13.55M | -5.59M | -2.89M | -1.24M |
Interest Income | 178.00K | 91.00K | n/a | 61.00K | 18.00K |
Pretax Income | -11.28M | -12.34M | -4.04M | -2.83M | -1.22M |
Net Income | -10.11M | -11.20M | -2.50M | -2.83M | -1.23M |
Selling & General & Admin | 4.78M | 7.14M | 2.50M | 393.00K | 337.00K |
Research & Development | 7.27M | 6.42M | 3.08M | 2.50M | 898.00K |
Other Expenses | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.29M | 13.55M | 5.59M | 2.89M | 1.24M |
Interest Expense | 550.00K | 15.00K | 1.15M | 1K | 5.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.29M | 13.55M | 5.59M | 2.89M | 1.24M |
Income Tax | n/a | -1.14M | -1.55M | 1K | 5.00K |
Shares Outstanding (Basic) | 13.64M | 11.50M | 1.94M | 1.94M | 1.94M |
Shares Outstanding (Diluted) | 13.64M | 11.50M | 1.94M | 1.94M | 1.94M |
EPS (Basic) | -0.83 | -0.97 | -1.29 | -1.46 | -0.63 |
EPS (Diluted) | -0.83 | -0.97 | -1.29 | -1.46 | -0.63 |
EBITDA | -10.63M | -13.38M | -2.88M | -2.83M | -1.25M |
Depreciation & Amortization | 97.00K | 89.00K | 3.00K | 3.00K | 1.24M |